Literature DB >> 7603570

Peripheral deletion of antigen-reactive T cells in oral tolerance.

Y Chen1, J Inobe, R Marks, P Gonnella, V K Kuchroo, H L Weiner.   

Abstract

Oral administration of antigen is used to induce antigen-specific peripheral immune tolerance. As well as preventing systemic immune responses to ingested proteins, oral tolerance to autoantigens has also been used to suppress autoimmune diseases in animals and humans. Both active suppression and clonal anergy are suggested to be mechanisms of oral tolerance, depending on the dose of antigen fed. Here we report that oral antigen can delete antigen-reactive T cells in Peyer's patches, in mice transgenic for the ovalbumin-specific T-cell receptor genes. The deletion was mediated by apoptosis, and was dependent on dosage and frequency of feeding. At lower doses deletion was not observed; instead there was induction of antigen-specific cells that produced transforming growth factor (TGF)-beta and interleukin (IL)-4 and IL-10 cytokines. At higher doses, both Th1 and Th2 cells were deleted following their initial activation, whereas cells which secrete TGF-beta were resistant to deletion. These findings demonstrate that orally administered antigen can induce tolerance not only by active suppression and clonal anergy but by extrathymic deletion of antigen-reactive Th1 and Th2 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603570     DOI: 10.1038/376177a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  154 in total

Review 1.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

4.  Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.

Authors:  R Weissert; A Lobell; K L de Graaf; S Y Eltayeb; R Andersson; T Olsson; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 5.  Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes.

Authors:  B S Lundin; M R Karlsson; L A Svensson; L A Hanson; U I Dahlgren; E Telemo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

7.  Oral tolerance, an active immunologic process mediated by multiple mechanisms.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 8.  Mucosal T cell response to reovirus.

Authors:  D Chen; D H Rubin
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 9.  The potential of peptide immunotherapy in allergy and asthma.

Authors:  F Runa Ali; A Barry Kay; Mark Larché
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 10.  Oral tolerance and gut-oriented immune response to dietary proteins.

Authors:  O Alpan
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.